Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Receivables - Net: 2009-2024

Historic Receivables - Net for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $279.3 million.

  • UNITED THERAPEUTICS's Receivables - Net fell 12.90% to $297.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $297.7 million, marking a year-over-year decrease of 12.90%. This contributed to the annual value of $279.3 million for FY2024, which is 0.14% up from last year.
  • As of FY2024, UNITED THERAPEUTICS's Receivables - Net stood at $279.3 million, which was up 0.14% from $278.9 million recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Receivables - Net registered a high of $279.3 million during FY2024, and its lowest value of $157.4 million during FY2020.
  • In the last 3 years, UNITED THERAPEUTICS's Receivables - Net had a median value of $278.9 million in 2023 and averaged $259.5 million.
  • Data for UNITED THERAPEUTICS's Receivables - Net shows a peak YoY climbed of 26.54% (in 2023) over the last 5 years.
  • UNITED THERAPEUTICS's Receivables - Net (Yearly) stood at $157.4 million in 2020, then rose by 26.24% to $198.7 million in 2021, then increased by 10.92% to $220.4 million in 2022, then climbed by 26.54% to $278.9 million in 2023, then climbed by 0.14% to $279.3 million in 2024.